How High Will Eli Lilly Stock Go By 2030?
The weight loss drugs market is heating up quickly and…
Buy
81
AU Quote, Financials, Valuation and Earnings
Last price:
$43.15
Seasonality move
:
-0.83%
Day range:
$42.62 - $44.37
52-week range:
$21.66 - $46.90
Dividend yield:
2.11%
P/E ratio:
19.43x
P/S ratio:
3.15x
P/B ratio:
3.28x
Volume:
5.7M
Avg. volume:
3.5M
1-year change:
95.82%
Market cap:
$21.7B
Revenue:
$5.8B
EPS (TTM):
$2.22
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.6B | $4B | $4.5B | $4.6B | $5.8B | |
| Revenue Growth (YoY) | 30.36% | -12.32% | 11.72% | 1.8% | 26.43% | |
| Cost of Revenues | $2.8B | $2.9B | $3.4B | $3.6B | $3.7B | |
| Gross Profit | $1.7B | $1.2B | $1.1B | $1B | $2.1B | |
| Gross Profit Margin | 38.02% | 29.04% | 25.08% | 22.41% | 35.68% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $85M | $90M | $87M | $99M | $162M | |
| Other Inc / (Exp) | $280M | $210M | -$293M | -$482M | $126M | |
| Operating Expenses | $250M | $373M | $296M | $452M | $514M | |
| Operating Income | $1.5B | $797M | $833M | $575M | $1.6B | |
| Net Interest Expenses | $150M | $58M | $68M | $30M | $7M | |
| EBT. Incl. Unusual Items | $1.6B | $949M | $472M | $63M | $1.7B | |
| Earnings of Discontinued Ops. | $7M | -- | -- | -- | -- | |
| Income Tax Expense | $625M | $311M | $221M | $285M | $623M | |
| Net Income to Company | $1.6B | -- | $472M | $63M | $1.7B | |
| Minority Interest in Earnings | -- | -$24M | -$18M | -$13M | -$45M | |
| Net Income to Common Excl Extra Items | $1B | $614M | $233M | -$235M | $1B | |
| Basic EPS (Cont. Ops) | $2.36 | $1.46 | $0.55 | -$0.56 | $2.33 | |
| Diluted EPS (Cont. Ops) | $2.36 | $1.46 | $0.55 | -$0.56 | $2.33 | |
| Weighted Average Basic Share | $419M | $419.8M | $420.2M | $421.1M | $430.1M | |
| Weighted Average Diluted Share | $419.5M | $420.1M | $420.9M | $421.1M | $430.9M | |
| EBITDA | $2.4B | $1.1B | $1.3B | $872M | $2.6B | |
| EBIT | $1.8B | $1.1B | $613M | $214M | $1.8B | |
| Revenue (Reported) | $4.6B | $4B | $4.5B | $4.6B | $5.8B | |
| Operating Income (Reported) | $1.5B | $797M | $833M | $575M | $1.6B | |
| Operating Income (Adjusted) | $1.8B | $1.1B | $613M | $214M | $1.8B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $1.3B | $1.8B | |
| Revenue Growth (YoY) | -- | -- | -- | 13.87% | 53.51% | |
| Cost of Revenues | -- | -- | -- | $950M | $973M | |
| Gross Profit | -- | -- | -- | $306M | $777M | |
| Gross Profit Margin | -- | -- | -- | 24.36% | 44.4% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | $36M | $76M | |
| Other Inc / (Exp) | -- | -- | -- | -$338M | $57M | |
| Operating Expenses | -- | -- | -- | -$185M | $133M | |
| Operating Income | -- | -- | -- | $491M | $644M | |
| Net Interest Expenses | -- | -- | -- | $9M | $3M | |
| EBT. Incl. Unusual Items | -- | -- | -- | $144M | $698M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $109M | $204M | |
| Net Income to Company | -- | -- | -- | $63M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -$7M | -$24M | |
| Net Income to Common Excl Extra Items | -- | -- | -- | $28M | $470M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | $0.06 | $1.03 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | $0.06 | $1.03 | |
| Weighted Average Basic Share | -- | -- | -- | $411.8M | $459.1M | |
| Weighted Average Diluted Share | -- | -- | -- | $411.8M | $462.3M | |
| EBITDA | -- | -- | -- | $182M | $733M | |
| EBIT | -- | -- | -- | $182M | $733M | |
| Revenue (Reported) | -- | -- | -- | $1.3B | $1.8B | |
| Operating Income (Reported) | -- | -- | -- | $491M | $644M | |
| Operating Income (Adjusted) | -- | -- | -- | $182M | $733M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $4.6B | $5.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | $3.6B | $3.8B | |
| Gross Profit | -- | -- | -- | $1B | $2.1B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | $99M | $167M | |
| Other Inc / (Exp) | -- | -- | -- | -$482M | -$222M | |
| Operating Expenses | -- | -- | -- | $452M | $184M | |
| Operating Income | -- | -- | -- | $575M | $1.9B | |
| Net Interest Expenses | -- | -- | -- | $30M | $23M | |
| EBT. Incl. Unusual Items | -- | -- | -- | $63M | $1.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $263M | $624M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -$13M | -$51M | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -$213M | $974M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -$0.51 | $2.22 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -$0.51 | $2.22 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | $354M | $1.8B | |
| EBIT | -- | -- | -- | $214M | $1.8B | |
| Revenue (Reported) | -- | -- | -- | $4.6B | $5.9B | |
| Operating Income (Reported) | -- | -- | -- | $575M | $1.9B | |
| Operating Income (Adjusted) | -- | -- | -- | $214M | $1.8B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2B | $2.2B | $4.6B | $4.6B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.4B | $1.6B | $3.6B | $2.8B | -- | |
| Gross Profit | $565M | $560M | $1B | $1.8B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $40M | $42M | $99M | $131M | -- | |
| Other Inc / (Exp) | $90M | $23M | -$482M | $116M | -- | |
| Operating Expenses | $122M | $139M | $452M | $369M | -- | |
| Operating Income | $443M | $421M | $575M | $1.4B | -- | |
| Net Interest Expenses | $26M | $34M | $30M | $14M | -- | |
| EBT. Incl. Unusual Items | $507M | $410M | $63M | $1.5B | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $134M | $94M | $263M | $515M | -- | |
| Net Income to Company | $507M | $410M | $63M | -- | -- | |
| Minority Interest in Earnings | -- | -$14M | -$13M | -$44M | -- | |
| Net Income to Common Excl Extra Items | $362M | $302M | -$213M | $946M | -- | |
| Basic EPS (Cont. Ops) | $0.86 | $0.72 | -$0.51 | $2.16 | -- | |
| Diluted EPS (Cont. Ops) | $0.86 | $0.72 | -$0.51 | $2.16 | -- | |
| Weighted Average Basic Share | $838M | $840M | $1.7B | $1.3B | -- | |
| Weighted Average Diluted Share | $838.1M | $840.1M | $1.7B | $1.3B | -- | |
| EBITDA | $775M | $762M | $354M | $1.6B | -- | |
| EBIT | $562M | $475M | $214M | $1.6B | -- | |
| Revenue (Reported) | $2B | $2.2B | $4.6B | $4.6B | -- | |
| Operating Income (Reported) | $443M | $421M | $575M | $1.4B | -- | |
| Operating Income (Adjusted) | $562M | $475M | $214M | $1.6B | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.3B | $1.2B | $1.1B | $964M | $1.4B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $56M | $50M | $20M | $25M | $47M | |
| Inventory | $733M | $703M | $773M | $829M | $1.1B | |
| Prepaid Expenses | -- | $41M | $58M | $41M | $59M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $2.3B | $2.1B | $2.1B | $2.5B | $3.4B | |
| Property Plant And Equipment | $3.1B | $3.7B | $4.4B | $4.6B | $8.6B | |
| Long-Term Investments | $1.8B | $1.8B | $1.1B | $600M | $584M | |
| Goodwill | $126M | $119M | $105M | $105M | $95M | |
| Other Intangibles | $5M | $3M | $1M | $2M | $3M | |
| Other Long-Term Assets | $100M | $59M | $38M | $36M | $199M | |
| Total Assets | $7.7B | $8B | $8B | $8.2B | $13.2B | |
| Accounts Payable | $403M | $406M | $356M | $432M | $566M | |
| Accrued Expenses | $191M | $67M | $151M | $128M | $141M | |
| Current Portion Of Long-Term Debt | $142M | $51M | $18M | $207M | $83M | |
| Current Portion Of Capital Lease Obligations | $37M | $61M | $71M | $73M | $76M | |
| Other Current Liabilities | -- | -- | $6M | $15M | $20M | |
| Total Current Liabilities | $959M | $827M | $884M | $1.2B | $1.4B | |
| Long-Term Debt | $1.8B | $1.9B | $2B | $2B | $1.9B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.9B | $3.9B | $3.9B | $4.4B | $4.6B | |
| Common Stock | $17M | -- | -- | $420M | $526M | |
| Other Common Equity Adj | -- | -- | $7.3B | $6.9B | $8.9B | |
| Common Equity | $3.7B | $4B | $4B | $3.7B | $6.6B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $45M | $54M | $35M | $29M | $1.9B | |
| Total Equity | $3.8B | $4.1B | $4.1B | $3.7B | $8.5B | |
| Total Liabilities and Equity | $7.7B | $8B | $8B | $8.2B | $13.2B | |
| Cash and Short Terms | $1.3B | $1.2B | $1.1B | $964M | $1.4B | |
| Total Debt | $1.9B | $1.9B | $2B | $2.2B | $2B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | $1.1B | $964M | $1.4B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | $237M | $25M | $47M | |
| Inventory | -- | -- | $773M | $829M | $1.1B | |
| Prepaid Expenses | -- | -- | -- | $41M | $59M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | -- | $2.1B | $2.5B | $3.4B | |
| Property Plant And Equipment | -- | -- | $4.4B | $4.6B | $8.6B | |
| Long-Term Investments | -- | -- | $1.1B | $600M | $584M | |
| Goodwill | -- | -- | -- | $105M | $95M | |
| Other Intangibles | -- | -- | -- | $2M | $3M | |
| Other Long-Term Assets | -- | -- | $38M | $36M | $199M | |
| Total Assets | -- | -- | $8.1B | $8.2B | $13.2B | |
| Accounts Payable | -- | -- | $710M | $432M | $566M | |
| Accrued Expenses | -- | -- | -- | $128M | $141M | |
| Current Portion Of Long-Term Debt | -- | -- | $18M | $207M | $83M | |
| Current Portion Of Capital Lease Obligations | -- | -- | $84M | $73M | $76M | |
| Other Current Liabilities | -- | -- | -- | $15M | $20M | |
| Total Current Liabilities | -- | -- | $859M | $1.2B | $1.4B | |
| Long-Term Debt | -- | -- | $2B | $2B | $1.9B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $3.9B | $4.4B | $4.6B | |
| Common Stock | -- | -- | $17M | $420M | $526M | |
| Other Common Equity Adj | -- | -- | $81M | $6.9B | $8.9B | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | $34M | $29M | $1.9B | |
| Total Equity | -- | -- | $4.1B | $3.7B | $8.5B | |
| Total Liabilities and Equity | -- | -- | $8.1B | $8.2B | $13.2B | |
| Cash and Short Terms | -- | -- | $1.1B | $964M | $1.4B | |
| Total Debt | -- | -- | -- | $2.2B | $2B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.6B | -- | $472M | $63M | $1.7B | |
| Depreciation & Amoritzation | $575M | -- | $637M | $658M | $752M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$163M | -- | -$152M | -$117M | -$182M | |
| Change in Inventories | -$83M | -- | -$54M | -$58M | -$78M | |
| Cash From Operations | $1.7B | $1.3B | $1.8B | $971M | $2B | |
| Capital Expenditures | $740M | $1B | $1B | $1B | $1.1B | |
| Cash Acquisitions | $29M | $2M | -- | -- | $66M | |
| Cash From Investing | -$514M | -$940M | -$1.5B | -$897M | -$762M | |
| Dividends Paid (Ex Special Dividend) | -$47M | -$240M | -$203M | -$107M | -$244M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2.2B | $822M | $266M | $343M | $655M | |
| Long-Term Debt Repaid | -$2.4B | -$883M | -$266M | -$181M | -$1B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$151M | -$35M | -$11M | -$20M | -$1M | |
| Cash From Financing | -$329M | -$456M | -$323M | -$87M | -$727M | |
| Beginning Cash (CF) | $456M | $1.3B | $1.2B | $1.1B | $955M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $849M | -$128M | $20M | -$13M | $479M | |
| Ending Cash (CF) | $1.3B | $1.2B | $1.1B | $955M | $1.4B | |
| Levered Free Cash Flow | $952M | $240M | $776M | -$71M | $878M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | $63M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | $658M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -$117M | |
| Change in Inventories | -- | -- | -- | -- | -$58M | |
| Cash From Operations | -- | -- | -- | -- | $404M | |
| Capital Expenditures | -- | -- | -- | -- | $334M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -$268M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$2M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | $250M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$27M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -$19M | |
| Cash From Financing | -- | -- | -- | -- | $163M | |
| Beginning Cash (CF) | -- | -- | -- | -- | $725M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -$69M | |
| Additions / Reductions | -- | -- | -- | -- | $299M | |
| Ending Cash (CF) | -- | -- | -- | -- | $955M | |
| Levered Free Cash Flow | -- | -- | -- | -- | $70M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | $971M | -- | |
| Capital Expenditures | -- | -- | -- | $1B | $334M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$897M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$107M | -$2M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $343M | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$181M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -$142M | -- | |
| Cash From Financing | -- | -- | -- | -$87M | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -$13M | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -$71M | -- | |
| Period Ending | 2021-04-23 | 2022-04-23 | 2023-04-23 | 2024-04-23 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get AU Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AU
Sector
P/E ratio
19.43x
15.89x
PEG ratio
--
0.00x
P/B ratio
3.28x
1.28x
Price / LTM sales
3.15x
1.41x
Growth Metrics
AU
Sector
Revenue growth
53.51%
1.11%
Earnings growth
275%
-0.1%
Revenue (5-year growth)
10.45%
3.88%
Earnings forecast
$0.89
$0.02
Profitability
AU
Sector
Profitability FY 2024
$2.1B
$12K
Return on invested capital
13.54%
2.08%
Return on assets
10.17%
1.39%
Return on equity
20.04%
2.85%
Earnings Date
Last Earnings Date
Feb
19
Next Earnings Date
May
9
Estimated Next Earnings Date
May
21
Balance Sheet
AU
Sector
Total cash
$1.4B
$2.6M
Short term investments
--
$447.6K
Total assets
$13.2B
$23.9M
Long term debt
$2B
$90.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is TSMC the Best Semiconductor Stock to Buy Now?
The new administration has launched a slew of tariffs, paused…
Rocket Lab Vs Intuitive Machines Stock
The commercialization of outer space is now in full swing,…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 30x
Sell
40
Is NVDA Stock a Buy?
Market Cap: $2.4T
P/E Ratio: 33x
Alerts
Buy
61
AGX alert for Apr 23
Argan [AGX] is up 3.08% over the past day.
Sell
44
INOD alert for Apr 22
Innodata [INOD] is up 5.26% over the past day.
Sell
44
UHS alert for Apr 22
Universal Health Services [UHS] is up 2.73% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
